INVESTOR ALERT: Investigation of Nutex Health, Inc. (NUTX) announced by Holzer & Holzer, LLC

Core Insights - Nutex Health, Inc. announced a revenue decrease of $105.9 million to $151.7 million for Q4 and fiscal year 2025, attributed to a one-time $55.0 million cumulative true-up of arbitration claims deemed ineligible [1] Group 1: Financial Performance - The revenue for the three months ended December 31, 2025, was significantly impacted by arbitration claims [1] - The stock price of Nutex Health dropped following the announcement of these financial results [1] Group 2: Legal Investigation - Holzer & Holzer, LLC is investigating whether Nutex Health complied with federal securities laws in light of the recent financial disclosures [1]